Skip to main content
. 2020 Dec 18;12:1758835920974192. doi: 10.1177/1758835920974192

Figure 3.

Figure 3.

Monitoring of the EGFRactivating and EGFRT790M alterations in circulating tumor DNA (ctDNA) samples collected before and after histological transformation. The levels of the EGFRdel19 or EGFRL858R (blue line) and EGFRT790M (red line) mutations (copies/ml of plasma) were measured by droplet digital PCR. Asterisks indicated ctDNA samples analyzed by NGS.

LC, lung carcinoma; NGS, next-generation sequencing; SCLC, small cell lung cancer.